slotkoers
Korea S.E.
00:00:00 03-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
6.780
KRW
|
0,00%
|
|
-1,31%
|
-16,91%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
567.258
|
542.459
|
536.260
|
345.507
|
240.563
|
278.246
|
Bedrijfswaarde
1 |
546.558
|
512.300
|
519.801
|
317.697
|
166.460
|
130.335
|
K/w-verhouding
|
-283
x
|
-38,4
x
|
-283
x
|
-498
x
|
78,4
x
|
35,3
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
12,8
x
|
11,8
x
|
11
x
|
6,3
x
|
3,75
x
|
4,05
x
|
Bedrijfswaarde/omzet
|
12,3
x
|
11,2
x
|
10,7
x
|
5,79
x
|
2,59
x
|
1,9
x
|
Bedrijfswaarde/EBITDA
|
-282
x
|
-160
x
|
195
x
|
-385
x
|
-13,8
x
|
-6,72
x
|
Bedrijfswaarde/FCF
|
-363
x
|
101
x
|
-21,8
x
|
-15,3
x
|
47,9
x
|
-3,44
x
|
FCF Yield
|
-0,28%
|
0,99%
|
-4,58%
|
-6,56%
|
2,09%
|
-29,1%
|
Price to Book
|
4,47
x
|
4,86
x
|
4,6
x
|
2,17
x
|
1,34
x
|
0,89
x
|
Aantal aandelen (in duizenden)
|
15.499
|
15.499
|
15.499
|
16.145
|
16.145
|
34.099
|
Referentieprijs
2 |
36.600
|
35.000
|
34.600
|
21.400
|
14.900
|
8.160
|
Datum van publicatie
|
11/03/19
|
13/03/20
|
19/03/21
|
21/03/22
|
15/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
44.384
|
45.811
|
48.625
|
54.856
|
64.201
|
68.643
|
EBITDA
1 |
-1.938
|
-3.200
|
2.670
|
-826,1
|
-12.052
|
-19.392
|
Bedrijfsresultaat (EBIT)
1 |
-6.593
|
-8.064
|
-2.433
|
-5.724
|
-17.434
|
-25.263
|
Operationele Marge
|
-14,85%
|
-17,6%
|
-5%
|
-10,44%
|
-27,15%
|
-36,8%
|
Resultaat voor belastingen (EBT)
1 |
-3.686
|
-8.011
|
307,2
|
602,4
|
6.508
|
4.414
|
Nettowinst (verlies)
1 |
-2.007
|
-14.120
|
-1.896
|
-683,3
|
3.069
|
5.840
|
Nettomarge
|
-4,52%
|
-30,82%
|
-3,9%
|
-1,25%
|
4,78%
|
8,51%
|
WPA
2 |
-129,5
|
-911,0
|
-122,3
|
-43,00
|
190,0
|
231,0
|
Free Cash Flow
1 |
-1.505
|
5.067
|
-23.825
|
-20.828
|
3.476
|
-37.893
|
FCF-marge
|
-3,39%
|
11,06%
|
-49%
|
-37,97%
|
5,41%
|
-55,2%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
113,29%
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
11/03/19
|
13/03/20
|
19/03/21
|
21/03/22
|
15/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
20.699
|
30.159
|
16.459
|
27.810
|
74.103
|
147.912
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-1.505
|
5.067
|
-23.825
|
-20.828
|
3.476
|
-37.893
|
ROE (netto-inkomsten/eigen vermogen)
|
-1,74%
|
-11,8%
|
-1,66%
|
-0,69%
|
1,01%
|
1,63%
|
ROA (netto-inkomsten/totale activa)
|
-2,57%
|
-2,59%
|
-0,7%
|
-1,51%
|
-3,34%
|
-3,73%
|
Totale activa
1 |
78.022
|
545.605
|
270.312
|
45.255
|
-91.795
|
-156.673
|
Nettoactief per aandeel
2 |
8.182
|
7.200
|
7.520
|
9.878
|
11.147
|
9.137
|
Cashflow per aandeel
2 |
408,0
|
768,0
|
599,0
|
668,0
|
920,0
|
1.100
|
Capex
1 |
1.293
|
9.309
|
7.850
|
10.175
|
3.227
|
2.560
|
Capex/omzet
|
2,91%
|
20,32%
|
16,14%
|
18,55%
|
5,03%
|
3,73%
|
Datum van publicatie
|
11/03/19
|
13/03/20
|
19/03/21
|
21/03/22
|
15/03/23
|
20/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -16,91% | 167 mln. | | +46,55% | 54,63 mld. | | -6,91% | 39,92 mld. | | +37,07% | 38,82 mld. | | +13,17% | 26,86 mld. | | -11,17% | 26,22 mld. | | -21,98% | 18,78 mld. | | +25,15% | 12,21 mld. | | +0,54% | 12,16 mld. | | +25,14% | 11,94 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|